Newsroom
Spotlight Story
UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association (HBA) as Luminary and Rising Star
Read more
Press Releases
UCB Launches Career-Advancing Scholarship Program for Adults Living with Hidradenitis Suppurativa…
Read More
BIMZELX® (bimekizumab-bkzx) demonstrates superior efficacy over SKYRIZI® (risankizumab-rzaa) in…
Read More
UCB to acquire Candid Therapeutics, building upon its existing immunology pipeline with novel T-…
Read More
UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy through…
Read More
UCB presents new data demonstrating quality-of-life impacts for epilepsy patients and caregivers at…
Read More
UCB announces new clinical data from its generalized myasthenia gravis (gMG) portfolio at the 2026…
Read MoreUCB Stories
Running Toward Relief: How Cassie is Reclaiming Her Life With Psoriatic Arthritis
Read More
UCB Issues Voluntary Recall of Select Lots of CIMZIA® Pre-Filled Syringes (PFS) in the United States
Read More
UCB’s Catherine Rives and Alexandria Harrold Recognized by Healthcare Businesswomen’s Association…
Read More
Evolving Expectations in Immunologic Disease: Our work with those living with immune-mediated…
Read More
3 in 3: Advancing hope for rare and ultra-rare disease communities, one innovation at a time
Read More
